Publications
2023
-
A tutorial on time-dependent cohort state-transition models in R using a cost-effectiveness analysis exampleMedical Decision Making, 2023
-
An introductory tutorial on cohort state-transition models in R using a cost-effectiveness analysis exampleMedical Decision Making, 2023
-
Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator programJNCI Monographs, 2023
2022
-
Exponential growth of drug overdose poisoning and opportunities for interventionAddiction, 2022
-
Reply commentary by Jalal and Burke.The International Journal on Drug Policy, 2022
-
APCtools: Descriptive and Model-based Age-Period-Cohort AnalysisJournal of Open Source Software, 2022
2021
-
BayCANN: streamlining Bayesian calibration with artificial neural network metamodelingFrontiers in Physiology, 2021 -
Carfentanil and the rise and fall of overdose deaths in the United StatesAddiction, 2021
-
Microsimulation model to compare enteral and parenteral iron supplementation in children with intestinal failureJournal of Parenteral and Enteral Nutrition, 2021
-
Future projection of the health and functional status of older people in Japan: A multistate transition microsimulation model with repeated cross-sectional dataHealth Economics, 2021
-
Data needs in opioid systems modeling: challenges and future directionsAmerican journal of preventive medicine, 2021
-
Towards a Public Health Approach to Homicides in MexicoAvailable at SSRN 3795313, 2021
-
Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? A value of information analysisVaccine, 2021
-
How simulation modeling can support the public health response to the opioid crisis in North America: setting priorities and assessing valueInternational Journal of Drug Policy, 2021
-
Prominent spatiotemporal waves of COVID-19 incidence in the United States: Implications for causality, forecasting, and controlmedRxiv, 2021
-
Recurring Spatiotemporal Patterns of COVID-19 in the United StatesmedRxiv, 2021
2020
-
Age and generational patterns of overdose death risk from opioids and other drugsNature medicine, 2020 -
Calculating the expected value of sample information in practice: considerations from 3 case studiesMedical Decision Making, 2020
-
A multidimensional array representation of state-transition model dynamicsMedical Decision Making, 2020
-
Associations between the specialty of opioid prescribers and opioid addiction, misuse, and overdose outcomesPain Medicine, 2020
-
Computing PROPr utility scores for PROMIS\textregistered profile instrumentsValue in Health, 2020
-
Computing the expected value of sample information efficiently: practical guidance and recommendations for four model-based methodsValue in Health, 2020
-
Developing and validating metamodels of a microsimulation model of infant HIV testing and screening strategies used in a decision support tool for health policy makersMDM Policy & Practice, 2020
-
Dissemination science to advance the use of simulation modeling: our obligation moving forwardMedical Decision Making, 2020
-
Hexamaps for age-period-cohort data visualization and implementation in REpidemiology (Cambridge, Mass.), 2020
-
Prioritizing additional data collection to reduce decision uncertainty in the HIV/AIDS response in 6 US cities: a value of information analysisValue in Health, 2020
2019
-
The curve of optimal sample size (COSS): a graphical representation of the optimal sample size from a value of information analysisPharmacoeconomics, 2019
-
“Time traveling is just too dangerous” but some methods are worth revisiting: the advantages of expected loss curves over cost-effectiveness acceptability curves and frontierValue in Health, 2019
-
A need for change! A coding framework for improving transparency in decision modelingPharmacoeconomics, 2019
2018
-
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016Science, 2018 -
A Gaussian approximation approach for value of information analysisMedical Decision Making, 2018 -
Microsimulation modeling for health decision sciences using R: a tutorialMedical Decision Making, 2018
2017
-
An overview of R in health decision sciencesMedical decision making, 2017
-
Prioritizing future research on allopurinol and febuxostat for the management of gout: value of information analysisPharmacoeconomics, 2017
-
Opportunity Cost Of Non-Rigorous Or Non-Transferable Research: Implications For Cost-Effectiveness AnalysisValue in Health, 2017
2016
-
Cost-effectiveness of triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritisArthritis care & research, 2016 -
Some health states are better than others: using health state rank order to improve probabilistic analysesMedical Decision Making, 2016
-
Forecasting trends in disability in a super-aging society: adapting the future elderly model to JapanThe Journal of the Economics of Ageing, 2016
2015
-
Computing expected value of partial sample information from probabilistic sensitivity analysis using linear regression metamodelingMedical Decision Making, 2015
-
Cost-effectiveness of a statewide campaign to promote aspirin use for primary prevention of cardiovascular diseaseJournal of the American Heart Association, 2015
-
Automating identification of multiple chronic conditions in clinical practice guidelinesAMIA Summits on Translational Science Proceedings, 2015
2013
-
Linear regression metamodeling as a tool to summarize and present simulation model resultsMedical Decision Making, 2013
2012
-
Network meta-analysis of margin threshold for women with ductal carcinoma in situJournal of the National Cancer Institute, 2012
2011
-
Including indirect medical care costs from survivor years of life in economic evaluationsPharmacoeconomics, 2011